Ampio initiates pivotal Ampion osteoarthritis trial
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More
Monday May 1, 2017 0 comments
Ampio: FDA discussions continue on best path forward for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it is continuing discussions with the CBER Division of the FDA to determine the best path forward to obtain a Biological... Read More
Thursday November 10, 2016 0 comments
Ampio Pharmaceuticals announces stock sale to investor to raise $3.75M
ENGLEWOOD -- Ampio Pharmaceuticals , Inc. (NYSE MKT: AMPE) announced it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of... Read More
Thursday September 1, 2016 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
